Colorectal carcinoma in black and white race

Cancer and Metastasis Reviews

Volumn 22, Issue 1, 2003, Pages 67-82

  Anderson, William F ^a   Umar, Asad ^a   Brawley, Otis W ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Chromosomal instability; Colorectal cancer screening; Colorectal carcinoma; Genetic susceptibility polymorphisms; Microsatellite instability; Racial variations

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CAROTENOID; FOLIC ACID;

ADENOMATOUS POLYP; AGING; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CARCINOMA IN SITU; COLORECTAL CARCINOMA; DESCENDING COLON; ETHNOLOGY; FRUIT; HIGH FIBER DIET; HIGH RISK POPULATION; HUMAN; MOLECULAR BIOLOGY; NUTRITION; PRIORITY JOURNAL; RACE; REVIEW; VEGETABLE;

AFRICAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; SURVIVAL RATE;

EID: 0037344881     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022264002228     Document Type: Review

References (144)

1. Jemal A, Thomas A, Murray T, Thun MJ: Cancer statistics, 2002. CA-A Cancer Journal For Clinicians 52: 23-47, 2002
2. SEER Cancer Statistics Review, 1973-1998
3. Easton D: Breast cancer-not just whether but when? Nat Genet 26: 390-391, 2000
4. Peto J: Cancer epidemiology in the last century and the next decade. Nature 411: 390-395, 2001
5. Chu KC, Tarone RE, Chow WH, Hankey BF, Ries LA: Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 86: 997-1006, 1994
6. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K, Edwards BK: The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88: 2398-2424, 2000
7. Wu XC, Chen VW, Steele B, Ruiz B, Fulton J, Liu L, Carozza SE, Greenlee R: Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer 92: 2547-2554, 2001
8. Chu KC, Tarone RE, Chow WH, Alexander GA: Colorectal cancer trends by race and anatomic subsites, 1975-1991. Arch Fam Med 4: 849-856, 1995
9. Troisi RJ, Freedman AN, Devesa SS: Incidence of colorectal carcinoma in the US: An update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 85: 1670-1676, 1999
10. Cordice JW Jr., Johnson H Jr.: Anatomic distribution of colonic cancers in middle-class black Americans. J Natl Med Assoc 83: 730-732, 1991
11. Devesa SS, Chow WH: Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 71: 3819-3826, 1993
12. Demers RY, Severson RK, Schottenfeld D, Lazar L: Incidence of colorectal adenocarcinoma by anatomic subsite. An epidemiologic study of time trends and racial differences in the Detroit, Michigan area. Cancer 79: 441-447, 1997
13. Johnson H Jr., Carstens R: Anatomical distribution of colonic carcinomas. Interracial differences in a community hospital population. Cancer 58: 997-1000, 1986
14. Thomas CR Jr., Jarosz R, Evans N: Racial differences in the anatomical distribution of colon cancer. Arch Surg 127: 1241-1245, 1992
15. Henschke UK, Leffall LD, Mason CH, Reinhold AW, Schneider RL, White JE: Alarming increase of the cancer mortality in the US black population (1950-1967). Cancer 31: 763-768, 1973
16. Freeman HP: The meaning of race in cancer of the breast. Cancer J Sci Am 3: 76-77, 1997
17. Day DW: The adenoma-carcinoma sequence. Scand J Gastroenterol Suppl 104: 99-107, 1984
18. Bertram JS: The molecular biology of cancer. Mol Aspects Med 21: 167-223, 2000
19. Renan MJ: How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 7: 139-146, 1993
20. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature 396: 643-649, 1998
21. Winawer SJ: A quarter century of colorectal cancer screening: Progress and prospects. J Clin Oncol 19: 6S-12S, 2001
22. Lindblom A: Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 13: 63-69, 2001
23. Liu B, Nicolaides NC, Markowitz S, Willson JK, Parsons RE, Jen J, Papadopolous N, Peltomaki P, de la Chapelle A, Hamilton SR, Kinzler K, Vogelstein B: Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 9: 48-55, 1995
24. Weber TK, Chin HM, Rodriguez-Bigas M, Keitz B, Gilligan R, O'Malley L, Urf E, Diba N, Pazik J, Petrelli NJ: Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. Jama 281: 2316-2320, 1999
25. Purtilo DT, Geelhoed GW, Li FP, Yang JP, Thurber WA, Darrah J, Cassel C: Mucinous colon carcinoma in a black family. Cancer Genet Cytogenet 24: 11-5, 1987
26. Carethers JM: Racial and ethnic factors in the genetic pathogenesis of colorectal cancer. J Assoc Acad Minor Phys 10: 59-67, 1999
27. Stolte M, Bethke B: Colorectal mini-de novo carcinoma: A reality in Germany too. Endoscopy 27: 286-290, 1995
28. Hawkins NJ, Ward RL: Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 93: 1307-1313, 2001
29. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, et al.: Identification of FAP locus genes from chromosome 5q21. Science 253: 661-665, 1991
30. Boland CR: In: The Genetic Basis of Human Cancer. Kinzler KW (ed) McGraw-Hill, New York, 1998, pp 333-346
31. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. New England Journal of Medicine 319: 525-532, 1988
32. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990
33. Carethers JM: The cellular and molecular pathogenesis of colorectal cancer. Gastroenterol Clin North Am 25: 737-754, 1996
34. Knudson AG Jr.: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823, 1971
35. Cavenee WK: Loss of heterozygosity in stages of malignancy. Clin Chem 35: B48-B52, 1989
36. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, et al.: Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816, 1993
37. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57: 808-811, 1997
38. Marra G, Boland CR: DNA repair and colorectal cancer. Gastroenterol Clin North Am 25: 755-772, 1996
39. Umar A, Kunkel TA: DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur J Biochem 238: 297-307, 1996
40. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S: A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998
41. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S: A national cancer institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89: 1758-1762, 1997
42. Muller A, Fishel R: Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest 20: 102-109, 2002
43. Hamilton SR: Origin of colorectal cancers in hyperplastic polyps and serrated adenomas: Another truism bites the dust. J Natl Cancer Inst 93: 1282-1283, 2001
44. Marra G, Boland CR: Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87: 1114-1125, 1995
45. Wijnen JT, Vasen HF, Khan PM, Zwinderman AH, van der Klift H, Mulder A, Tops C, Moller P, Fodde R: Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339: 511-518, 1998
46. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, Vogelstein B, Kinzler KW: Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2: 169-174, 1996
47. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561, 1993
48. Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Nystrom-Lahti M, Seruca R, David L, Holm R, Ryberg D, Haugen A, et al.: Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53: 5853-5855, 1993
49. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomaki P, Mecklin JP, Jarvinen HJ: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81: 214-218, 1999
50. Lynch HT, Smyrk T, Watson P, Lanspa SJ, Boman BM, Lynch PM, Lynch JF, Cavalieri J: Hereditary colorectal cancer. Semin Oncol 18: 337-366, 1991
51. Jaskiewicz K, Lancaster E, Banach L, Karmolinski A: Proliferative activity of normal and neoplastic colonic mucosa in population groups with high and low risk for colorectal carcinoma. Anticancer Res 18: 4641-4644, 1998
52. Adebamowo CA, Adeyi O, Pyatt R, Prior TW, Chadwick RB, de la Chapelle A: Case report on hereditary non-polyposis colon cancer (HNPCC) in Nigeria. Afr J Med Med Sci 29: 71-73, 2000
53. Skalsky JA: Colorectal cancer in young black patients. Trop Doct 19: 185, 1989
54. Degiannis E, Sliwa K, Levy R, Hale MJ, Saadia R: Clinicopathological trends in colorectal carcinoma in a Black South African population. Trop Gastroenterol 16: 55-61, 1995
55. Lockhart-Mummery JP, Dukes C: The precancerous changes in the rectum and colon. Surgery, Gynecology & Obstetrics XLVI: 591-596, 1928
56. Morson BC: Evolution of cancer of the colon and rectum. Cancer 34: suppl: 845-849, 1974
57. Morson B: President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med 67: 451-457, 1974
58. Wolfe WI, Shinya H: Polypectomy via the fiberoptic colonoscopy removal of neoplasms beyond reach of the sigmoidoscope. N Engl J Med 288: 329-332, 1973
59. Wolfe WI, Shinya H: Endoscopic polypectomy. Therapeutic and clinicopathologic aspects. Cancer 36: 683-690, 1975
60. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, et al.: Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N Engl J Med 329: 1977-1981, 1993
61. Winawer SJ, Zauber AG, O'Brien MJ, Gottlieb LS, Sternberg SS, Stewart ET, Bond JH, Schapiro M, Panish JF, Waye JD, et al.: The national polyp study. Design, methods, and characteristics of patients with newly diagnosed polyps. The national polyp study workgroup. Cancer 70: 1236-1245, 1992
62. Sporn MB: Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 36: 2699-2702, 1976
63. Atkin WS, Morson BC, Cuzick J: Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326: 658-662, 1992
64. Rex DK, Cummings OW, Helper DJ, Nowak TV, McGill JM, Chiao GZ, Kwo PY, Gottlieb KT, Ikenberry SO, Gress FG, Lehman GA, Born LJ: 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons [see comment]. Gastroenterology 111: 1178-1181, 1996
65. Stryker SJ, Wolff BG, Culp CE, Libbe SD. Ilstrup DM, MacCarty RL: Natural history of untreated colonic polyps. Gastroenterology 93: 1009-1013, 1987
66. Villavicencio RT, Rex DK: Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy. Semin Gastrointest Dis 11: 185-193, 2000
67. Bremner CG, Ackerman LV: Polyps and carcinoma of the large bowel in the South African bantu. Cancer 26: 991-999, 1970
68. Segal I: Rarity of colorectal adenomas in the African black population. Eur J Cancer Prev 7: 387-391. 1998
69. Jackson L, Ally R, Segal I: A comparative study of colonoscopic findings at the Johannesburg and Baragwanath Hospitals. S Afr J Surg 83: 793a, 1993
70. Williams AO, Prince DL: Intestinal polyps in the Nigerian African. J Clin Pathol 28: 367-371, 1975
71. Williams AO, Chung EB, Agbata A, Jackson MA: Intestinal polyps in American negroes and Nigerian Africans. Br J Cancer 31: 485-491, 1975
72. Correa P, Strong JP, Reif A, Johnson WD: The epidemiology of colorectal polyps: prevalence in New Orleans and international comparisons. Cancer 39: 2258-2264, 1977
73. Rex DK, Khan AM, Shah P, Newton J, Cummings OW: Screening colonoscopy in asymptomatic average-risk African Americans. Gastrointest Endosc 51: 524-527, 2000
74. Ozick LA, Jacob L, Donelson SS, Agarwal SK, Freeman HP: Distribution of adenomatous polyps in African-Americans. Am J Gastroenterol 90: 758-760, 1995
75. Offerhaus GJ, Giardiello FM, Tersmette KW, Mulder JW, Tersmette AC, Moore GW, Hamilton SR: Ethnic differences in the anatomical location of colorectal adenomatous polyps. Int J Cancer 49: 641-644, 1991
76. Johnson H Jr, Margolis I, Wise L: Site-specific distribution of large-bowel adenomatous polyps. Emphasis on ethnic differences. Dis Colon Rectum 31: 258-260, 1988
77. Armitage P, Doll R: A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. British Journal of Cancer 11: 161-169, 1957
78. Armitage P, Doll R: The age distribution of cancer and a multi-stage theory of carcinogenesis. British Journal of Cancer 8: 1-12, 1954
79. Ishibe N, Freedman AN: Understanding the interaction between environmental exposures and molecular events in colorectal carcinogenesis. Cancer Invest 19: 524-539, 2001
80. Peto J, Houlston RS: Genetics and the common cancers. Eur J Cancer 37 Suppl 8: 88-96, 2001
81. Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO: The role of gene-environment interaction in the aetiology of human cancer: Examples from cancers of the large bowel, lung and breast. J Intern Med 249: 477-493, 2001
82. Perera FP, Weinstein IB: Molecular epidemiology: Recent advances and future directions. Carcinogenesis 21: 517-524, 2000
83. Houlston RS, Tomlinson IP: Polymorphisms and colorectal tumor risk. Gastroenterology 121: 282-301, 2001
84. Hirvonen A: Chapter 20. Polymorphic NATs and cancer predisposition. IARC Sci Publ 251-270, 1999
85. Pistorius S, Schackert HK, Saeger HD: [In Process Citation]. Kongressbd Dtsch Ges Chir Kongr 118: 820-824, 2001
86. Bechtel YC, Bechtel PR, Lelouet H, Choisy H, Dy NR: The acetylator polymorphism in a Khmer population: clinical consequences. Therapie 56: 409-413, 2001
87. Zaridze DG: Environmental etiology of large-bowel cancer. J Natl Cancer Inst 70: 389-400, 1983
88. Giovannucci E, Goldin B: The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr 66: 1564S-1571S, 1997
89. Potter JD: Colorectal cancer: Molecules and populations. J Natl Cancer Inst 91: 916-932, 1999
90. Anti M, Marra G, Armelao F, Percesepe A, Gentiloni N: Modulating effect of omega-3 fatty acids on the proliferative pattern of human colorectal mucosa. Adv Exp Med Biol 400B: 605-610, 1997
91. Sinha R, Rothman N, Brown ED, Salmon CP, Knize MG, Swanson CA, Rossi SC, Mark SD, Levander OA, Felton JS: High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method. Cancer Res 55: 4516-4519, 1995
92. Ohgaki H, Takayama S, Sugimura T: Carcinogenicities of heterocyclic amines in cooked food. Mutat Res 259: 399-410, 1991
93. Chen J, Stampfer MJ, Hough HL, Garcia-Closas M, Willett WC, Hennekens CH, Kelsey KT, Hunter DJ: A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 58: 3307-3311, 1998
94. Dickel H, Taylor JS, Evey P, Merk HF: Comparison of patch test results with a standard series among white and black racial groups. Am J Contact Dermat 12: 77-82, 2001
95. Probst-Hensch NM, Haile RW, Ingles SA, Longnecker MP, Han CY, Lin BK, Lee DB, Sakamoto GT, Frankl HD, Lee ER, et al.: Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res 55: 2017-2020, 1995
96. Scordo MG, Aklillu E, Yasar U, Dahl ML, Spina E, Ingelman-Sundberg M: Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population. Br J Clin Pharmacol 52: 447-450, 2001
97. Rushmore TH, Pickett CB: Glutathione S-transferases, structure, regulation, and therapeutic implications. J Biol Chem 268: 11475-11478, 1993
98. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD: Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4: 589-594, 1995
99. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW: GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22: 129-138, 1998
100. Burkitt DP: Epidemiology of cancer of the colon and rectum. Cancer 28: 3-13, 1971
101. Sengupta S, TJandra JJ, Gibson PR: Dietary fiber and colorectal neoplasia. Dis Colon Rectum 44: 1016-1033, 2001
102. Block G, Patterson B, Subar A: Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 18: 1-29, 1992
103. Gridley G, McLaughlin JK, Block G, Blot WJ, Gluch M, Fraumeni JF Jr.: Vitamin supplement use and reduced risk of oral and pharyngeal cancer. Am J Epidemiol 135: 1083-1092, 1992
104. Steinmetz KA, Potter JD: Vegetables, fruit, and cancer prevention: A review. J Am Diet Assoc 96: 1027-1039, 1996
105. Slaga TJ, Klein-Szanto AJ, Triplett LL, Yotti LP, Trosko KE: Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 213: 1023-1025, 1981
106. Klein-Szanto AJ, Slaga TJ: Effects of peroxides on rodent skin: Epidermal hyperplasia and tumor promotion. J Invest Dermatol 79: 30-34, 1982
107. Nakamura Y, Colburn NH, Gindhart TD: Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA. Carcinogenesis 6: 229-235, 1985
108. Freudenheim JL, Graham S, Marshall JR, Haughey BP, Cholewinski S, Wilkinson G: Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 20: 368-374, 1991
109. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC: Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87: 265-273, 1995
110. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, Speizer FE, Willett WC: Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85: 875-884, 1993
111. Estrada DA, Billett HH: Racial variation in fasting and random homocysteine levels. Am J Hematol 66: 252-256, 2001
112. Botto LD, Yang Q: 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am J Epidemiol 151: 862-877, 2000
113. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE: Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22: 195-201, 2001
114. Peng F, Labelle LA, Rainey BJ, Tsongalis GJ: Single nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene are common in US Caucasian and Hispanic American populations. Int J Mol Med 8: 509-511, 2001
115. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FE, Willett WC: Multivitamin use, folate, and colon cancer in women in the nurses' health study. Ann Intern Med 129: 517-524, 1998
116. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ: Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56: 142-150, 1995
117. Levine AJ, Siegmund KD, Ervin CM, Diep A, Lee ER, Frankl HD, Haile RW: The methylenetetrahydrofolate reductase 677C->T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 9: 657-663, 2000
118. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC, Hunter DJ: A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56: 4862-4864, 1996
119. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R: Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57: 1098-1102, 1997
120. Chen J, Giovannucci E, Hankinson SE, Ma J, Willett WC, Spiegelman D, Kelsey KI, Hunter DJ: A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 19: 2129-2132, 1998
121. Ponder BA: Cancer genetics. Nature 411: 336-341, 2001
122. Gerstenberger PD, Plumeri PA: Malpractice claims in gastrointestinal endoscopy: Analysis of an insurance industry data base. Gastrointest Endosc 39: 132-138, 1993
123. Smith RA, Mettlin CJ, Davis KJ, Eyre H: American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometerial cancers. CA Cancer J Clin 51: 38-75, 2001
124. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A: Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 95: 868-877, 2000
125. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ: Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 112: 594-642, 1997
126. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C: A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 317: 559-565, 1998
127. Muller AD, Sonnenberg A: Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 155: 1741-1748, 1995
128. Muller AD, Sonnenberg A: Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32, 702 veterans. Ann Intern Med 123: 904-910, 1995
129. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM: Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84: 1572-1575, 1992
130. Selby JV, Friedman GD, Quesenberry CP Jr., Weiss NS: A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326: 653-657, 1992
131. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF: Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343: 169-174, 2000
132. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans affairs cooperative study group 380. N Engl J Med 343: 162-168, 2000
133. Lieberman DA, Weiss DG: One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345: 555-560, 2001
134. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med 328: 1365-1371, 1993
135. Vernon SW: Participation in colorectal cancer screening: A review. J Natl Cancer Inst 89: 1406-1422, 1997
136. Woolf SH: The best screening test for colorectal cancer - a personal choice. N Engl J Med 343: 1641-1643, 2000
137. Trends in Screening for Colorectal Cancer - United States, 1997 and 1999. Morbidity and Mortality Weekly Report 50: 162, 2001
138. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R: Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 national health interview surveys. J Natl Cancer Inst 93: 1704-1713, 2001
139. Lin HJ, Probst-Hensch NM, Hughes NC, Sakamoto GT, Louie AD, Kau IH, Lin BK, Lee DB, Lin J, Frankl HD, Lee ER, Hardy S, Grant DM, Haile RW: Variants of N-acetyltransferase NATI and a case-control study of colorectal adenomas. Pharmacogenetics 8: 269-281, 1998
140. Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J, Brubaker LH, Kadlubar FF, Lucier GW: Genotype/phenotype discordance for human arylamine N-acetyl-transferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14: 1689-1692, 1993
141. Lin HJ, Han CY, Lin BK, Hardy S: Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: Application to metabolic epidemiology. Am J Hum Genet 52: 827-834, 1993
142. Cascorbi I, Brockmoller J, Roots I: A C4887A polymorphism in exon 7 of human CYP 1A1: Population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56: 4965-4969, 1996
143. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E: Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10: 1239-1248, 2001
144. Ford JG, Li Y, O'Sullivan MM, Demopoulos R, Garte S, Taioli E, Brandt-Rauf PW: Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis 21: 1971-1975, 2000